Janus Henderson Group’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387K | Sell |
16,868
-107,534
| -86% | -$2.47M | ﹤0.01% | 2067 |
|
|
2025
Q1 | $3.54M | Sell |
124,402
-64,945
| -34% | -$1.85M | ﹤0.01% | 1016 |
|
|
2024
Q4 | $7.03M | Buy |
189,347
+42,302
| +29% | +$1.57M | ﹤0.01% | 805 |
|
|
2024
Q3 | $7.14M | Sell |
147,045
-9,219
| -6% | -$447K | ﹤0.01% | 770 |
|
|
2024
Q2 | $6.25M | Sell |
156,264
-2,934
| -2% | -$117K | ﹤0.01% | 768 |
|
|
2024
Q1 | $6.99M | Sell |
159,198
-6,000
| -4% | -$263K | ﹤0.01% | 774 |
|
|
2023
Q4 | $10.2M | Buy |
165,198
+52,618
| +47% | +$3.25M | 0.01% | 664 |
|
|
2023
Q3 | $5.18M | Buy |
112,580
+15,505
| +16% | +$713K | ﹤0.01% | 806 |
|
|
2023
Q2 | $5.58M | Sell |
97,075
-6,866
| -7% | -$395K | ﹤0.01% | 837 |
|
|
2023
Q1 | $3.9M | Buy |
103,941
+96,226
| +1,247% | +$3.61M | ﹤0.01% | 956 |
|
|
2022
Q4 | $216K | Hold |
7,715
| – | – | ﹤0.01% | 2153 |
|
|
2022
Q3 | $217K | Sell |
7,715
-52
| -0.7% | -$1.46K | ﹤0.01% | 2370 |
|
|
2022
Q2 | $270K | Sell |
7,767
-355,737
| -98% | -$12.4M | ﹤0.01% | 2143 |
|
|
2022
Q1 | $13M | Sell |
363,504
-609,689
| -63% | -$21.9M | 0.01% | 840 |
|
|
2021
Q4 | $22.7M | Buy |
973,193
+2,642
| +0.3% | +$61.5K | 0.01% | 756 |
|
|
2021
Q3 | $18.5M | Buy |
970,551
+415,515
| +75% | +$7.9M | 0.01% | 814 |
|
|
2021
Q2 | $11.2M | Buy |
+555,036
| New | +$11.2M | ﹤0.01% | 918 |
|